Diagnosis and Treatment of Genitourinary Syndrome of Menopause

Academic Article

Abstract

  • © 2018 AWHONN Genitourinary syndrome of menopause (GSM), formerly referred to as vulvovaginal atrophy or atrophic vaginitis, is a common chronic condition that requires a collaborative treatment plan between a health care provider and a woman to relieve symptoms and improve quality of life. Many women are not aware that symptoms can be controlled with treatment. Current treatment options approved for GSM include vaginal moisturizers, lubricants, and hormones. For women with GSM symptoms that are unresponsive to nonhormonal therapy, low-dose vaginal estrogen therapy is the preferred pharmacologic treatment. Clinicians should be trained to routinely ask appropriate questions during the history to elicit sufficient information to assess for GSM. Physical examination findings may further confirm suspicion of GSM.
  • Published In

  • Awhonn Lifelines  Journal
  • Digital Object Identifier (doi)

    Author List

  • Hodges AL; Holland AC; Dehn B; Pace DT
  • Start Page

  • 423
  • End Page

  • 430
  • Volume

  • 22
  • Issue

  • 5